Apoxis SA
Switzerland
acquired
acquired
Stage
About
Apoxis SA was a Swiss company developing therapeutics targeting cell death, inflammation, and angiogenesis for the treatment of cancer and autoimmune diseases.
Explore Apoxis SA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.